Skip to main content
← All guides

Federal obligations in pharmaceutical preparation manufacturing (NAICS 325412)

Federal contract awards coded NAICS 325412, pharmaceutical preparation manufacturing, carry $59,825,795,303.53 in obligations in the USAspending.gov records indexed here. The total spans 51,311 awards. These are obligations, not outlays. The code is finished-dose drug manufacturing, not biological products except diagnostic (325414), not physician offices (621111), and not health-insurance carriers (524114).

Key figures

  • Pharmaceutical preparation manufacturing (NAICS 325412) shows $59,825,795,303.53 in obligations.
  • Those dollars sit on 51,311 contract awards, not a count of drugs or prescriptions.
  • 325412 is finished-dose manufacturing, not biological products (325414) or clinic care.
  • Figures are USAspending contract obligations, not outlays or benefit payments.

What pharmaceutical preparation manufacturing covers

NAICS 325412 covers establishments that manufacture pharmaceutical preparations: finished drugs in dose form. On USAspending.gov the code tags contract awards classified that way—federal purchases of manufactured medicines, stockpiles, and related production contracts. It is not a count of prescriptions filled, and it is not a list of every pill in a federal formulary. The NAICS follows the award’s industry classification.

Biological product manufacturing except diagnostic (vaccines, blood fractions, and similar) is 325414. Clinical care in physician offices is 621111. Insurance-carrier contracting is 524114. A health program can buy drugs under 325412 while buying clinic care and plan administration under other codes. The $59.8 billion figure is only the pharmaceutical-preparation slice.

Reading $59.8 billion as contract obligations

USAspending records obligations on contract awards tagged 325412. Delivery orders, stockpile buys, and modifications all feed $59,825,795,303.53. This packet has no fiscal-year split and no outlay total. A multi-year pharmaceutical contract can show a large obligation while shipments and invoices continue.

Outlays are the payments. Quote $59.8 billion as USAspending contract obligations coded to pharmaceutical preparation manufacturing. Do not describe it as Medicare Part D, as Medicaid drug spending, or as cash already disbursed unless those dollars actually appear as 325412 contract awards—which this packet does not claim.

51,311 awards on a drug-manufacturing code

The 51,311 award records are consistent with many delivery orders for specific products rather than a handful of exclusive licenses. The count is not 51,311 drugs and not 51,311 manufacturers. One schedule contract can generate thousands of orders. Use the industry page to see how those rows concentrate.

Pharmacy-contract headlines often mix manufacturing, claims, and research. NAICS 325412 is manufacturing of pharmaceutical preparations: $59,825,795,303.53 in USAspending obligations on 51,311 awards. The high award count is delivery-order volume on schedules and stockpile vehicles, not 51,311 distinct molecules. Biologicals except diagnostics are 325414. Biotech R&D is 541711 or 541714. Physician offices are 621111. Carriers are 524114. Medicare claims are not a NAICS table. This page is not medical advice. Quote USAspending.gov, quote obligations, quote 51,311 awards, and keep benefit-program financial statements in their own lane. Outlays are not in the packet.

What 325412 excludes

Assistance awards often lack NAICS and are outside this total. Research contracts tagged to biotech R&D codes are research, not finished-dose manufacturing. Diagnostic biologicals, if classified under other chemical or medical NAICS lines, sit elsewhere. This page does not offer medical advice; it restates a contracting rollup.

SpendingVault aggregates USAspending.gov contract data. The $59,825,795,303.53 total and the 51,311 award count can change after corrections. The live industry page is the table of record.

Using the pharmaceutical industry page

Open the PHARMACEUTICAL PREPARATION MANUFACTURING industry page for the award list under the headline. Compare 325412 with 325414 and with clinical and insurance codes on All industries. Cite obligations, not outlays, and keep the 51,311 award count with the dollar figure.

Citing drug-manufacturing contracts without benefit claims

Cite $59,825,795,303.53 in USAspending obligations on 51,311 awards tagged NAICS 325412, pharmaceutical preparation manufacturing. Then limit the claim: finished-dose manufacturing contracts, not Medicare claims, not Medicaid, not biological-product manufacturing.

The 51,311 award count is delivery-order volume. It is not 51,311 drugs. This page is not medical advice and not a formulary. Outlays are not in the packet. Grants are generally outside. If a stockpile buy was tagged 325414 instead, it will not be inside this $59.8 billion total.

Finished-dose manufacturing is a product NAICS, not a benefit NAICS. The $59,825,795,303.53 total is contract awards tagged 325412, including the 51,311 delivery-order-like records typical of pharmaceutical schedules. A stockpile buy and a routine pharmacy-contract order can share the code. Neither is a Medicare claim.

This page will not interpret whether a given drug was appropriate. It will not count prescriptions. Biologicals except diagnostics belong on 325414 when tagged that way. Clinics belong on 621111. Carriers belong on 524114. Quote USAspending obligations, 51,311 awards, and pharmaceutical preparation manufacturing, then stop. Outlays are not in the packet.

Questions

How much is obligated on NAICS 325412 pharmaceutical manufacturing?
USAspending.gov contract awards coded NAICS 325412 show $59,825,795,303.53 in obligations across 51,311 awards. That total is obligations, not outlays, for pharmaceutical preparation manufacturing. USAspending.gov records the amount as contract obligations, not outlays, on awards tagged NAICS 325412.
Does this include vaccines and blood products?
Biological product (except diagnostic) manufacturing is NAICS 325414. This table’s $59,825,795,303.53 is pharmaceutical preparations tagged 325412. Vaccine dollars tagged 325414 do not roll into this total. The packet total is $59,825,795,303.53 across 51,311 awards; assistance awards often have no NAICS and stay outside the industry rollup.
Is this Medicare or Medicaid drug spending?
This page is a NAICS rollup of contract awards, totaling $59,825,795,303.53. It is not a program financial statement for Medicare or Medicaid. Benefit payments that are not 325412 contract awards are outside the table. Treat the 51,311 figure as an award-record count, including orders and modifications, not as a physical inventory of products or sites.
Do 51,311 awards mean 51,311 drugs?
No. The 51,311 figure counts contract award records, including delivery orders and modifications. It is not a count of distinct drug products. This guide does not add a fiscal-year split. Quote the live industry page if you need the current award list under PHARMACEUTICAL PREPARATION MANUFACTURING.

NAICS from USAspending contract awards. Assistance awards may not carry NAICS.